Bifidobacterium longum 35624 for IBS: Why the Full Strain Name Matters
The probiotic once called B. infantis 35624 has IBS trials behind it, but strain identity, dose and product viability determine what those results mean.

B. longum 35624 has strain-specific IBS trials, but the results do not transfer to every Bifidobacterium product. Match the full strain, dose and shelf-life promise.
A probiotic name is more like an address
A label that says Bifidobacterium is not specific enough to predict an IBS result. Genus, species and strain identify progressively narrower groups, and clinical findings belong to the tested strain. Bifidobacterium longum 35624 is a well-known example because it has appeared in randomized IBS studies under an older name.
Many papers call it Bifidobacterium infantis 35624. Taxonomic work later placed the organism within B. longum, so both names can appear in research and product discussions. Our guide to why probiotic strain evidence matters explains the larger rule: a shared genus does not make two organisms clinically interchangeable.

What IBS trials reported
A large randomized trial in women with IBS compared three doses of encapsulated 35624 with placebo for four weeks. The middle dose produced the clearest improvement across several symptom measures, while another dose had manufacturing-related dissolution problems. The study is a useful warning that both dose and delivery can shape the result.
An earlier randomized study compared the strain with another probiotic and placebo and measured symptoms as well as immune signaling. It reported symptom improvement with 35624. These findings support a strain-specific signal, but they do not establish that all IBS subtypes respond or that benefits continue indefinitely after the studied period.
Bloating research needs its own context
A later trial tested 35624 in people from the general population who had abdominal discomfort and bloating but did not have a formal IBS diagnosis. The overall group did not show a significant advantage over placebo, although subgroup findings generated questions for later research. That result should not be blended into an IBS claim without context.
IBS trials also carry a substantial placebo response because symptoms fluctuate and expectation matters. Look for prespecified outcomes, adequate sample size and the exact population. A fermented-food versus probiotic-capsule comparison is a separate question: foods contain variable organisms and do not automatically deliver strain 35624.

How to read a 35624 label
Look for the complete designation, not just B. longum or B. infantis. Check whether the colony-forming-unit count is promised through expiration rather than only at manufacture. The probiotic CFU and shelf-life guide explains why storage temperature, moisture protection and the date on the package affect the dose that reaches you.
Do not assume that a higher CFU number is superior. The 35624 dose-response trial did not produce a simple more-is-better curve. Also avoid combining several probiotics at once. Synbiotic combinations are not automatically additive, and a prebiotic ingredient can change gas or bloating independently.
A measured trial and safety check
If a clinician agrees, choose a product that clearly lists 35624, follow its labeled dose and hold other gut supplements steady. Track pain, bloating and stool pattern for a defined period. Stop if symptoms reliably worsen. Probiotics are not a substitute for evaluation of bleeding, weight loss, fever, anemia or severe pain.
Most healthy adults tolerate common probiotics, but people who are severely ill, immunocompromised or living with central venous access should ask their care team first because rare infections have been reported with probiotic organisms. The useful question is not whether probiotics work. It is whether this exact strain has evidence for your exact goal.
Product names can change while strain numbers remain stable, so keep a photo of the label if you are tracking results. Check whether the capsule also contains fibers that may increase gas. A useful trial has one clear start date, a stable diet and a stop date for reassessment. Continuing indefinitely without knowing whether symptoms changed turns a careful experiment into an expensive habit. Keep the lot number if you report an adverse event or quality concern. Refrigerate only when the package directs it, since storage requirements differ. Discard damaged or improperly stored capsules rather than assuming the stated CFU count still applies.
If the full strain number is missing, treat the product as a different probiotic rather than assuming the familiar species name is close enough.